-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eribulin Mesylate in Metastatic Transitional (Urothelial) Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eribulin Mesylate in Metastatic Transitional (Urothelial) Tract Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eribulin Mesylate in Metastatic Transitional (Urothelial) Tract...
-
Product Insights
Pulmonary Sarcoidosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Pulmonary Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Pulmonary Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Ductal Carcinoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Ductal Carcinoma - Drugs In Development, 2023’, provides an overview of the Ductal Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ductal Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Sarcoidosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OATD-01 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OATD-01 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OATD-01 in Idiopathic Pulmonary Fibrosis Drug Details: GLPG-4716 is under development for...
-
Product Insights
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline Market Report Overview Inflammatory Disease Markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity. The Inflammatory Disease Markers pipeline market research report provides comprehensive information about the inflammatory disease markers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests ·       C-Reactive Protein (CRP)...
-
Track & Monitor
Innovation in Pharmaceuticals: Boric acid derivatives
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...